# FDA recall D-1547-2022

> **Akorn, Inc.** · Class II · drug recall initiated 2022-09-21.

## Product

Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Operating Company, LLC, Gurnee, IL 60031,  NDC 61748-015-30

## Reason for recall

Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).

## Distribution

USA Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-1547-2022
- **Recalling firm:** Akorn, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2022-09-21
- **Report date:** 2022-10-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Gurnee, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1547-2022

## Citation

> AI Analytics. FDA recall D-1547-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1547-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*